Home > IMPLEMENTATION OF THE EUROPEAN « BASIC SAFETY STANDARDS » DIRECTIVE: CURRENT STATUS, CLINICAL AND ECONOMICAL IMPLICATIONS - a joint BELNUC / VBS-GBS seminar
<< Back to the News

IMPLEMENTATION OF THE EUROPEAN « BASIC SAFETY STANDARDS » DIRECTIVE: CURRENT STATUS, CLINICAL AND ECONOMICAL IMPLICATIONS - a joint BELNUC / VBS-GBS seminar

Published on 30.11.2017

MORE INFO ON VENUE & REGISTRATION WILL COME ON THE BELNUC EVENT CALENDAR!

 

Dear colleagues,

Dear members,

 

The European Commission has issued a new directive regarding the Basic Safety Standards (Council Directive 2013/59/Euratom of 5 December 2013). This directive should be transposed into national legislation before February 6, 2018. The FANC-AFCN is in charge for preparing a Royal Decree to that effect. More info on these meetings and the project can be found on the website of FANC-AFCN

 

As soon as we were informed of this process, BELNUC set up a working group with NM physicians, physicists and radiopharmacists in order to study the European directive and evaluate its potential impact on our practice. This was done in coordination with VBS-GBS. Furthermore, both BELNUC and VBS-GBS have been in contact with the FANC-AFCN. Several meetings took place before the release of a project of Royal Decree this summer. Although we had ample opportunity to express our views, we must admit we were disappointed in the proposal. We have submitted to the FANC-AFCN our remarks and comments in due time (Dutch versionFrench version), and we further expressed those concerns during the round table organized by the FANC-AFCN on September 28, 2017. A last meeting was held on November 21 to discuss specifically some of the aspects related to radionuclide treatments with the FANC-VBS and the BHPA.  

At this stage we do not know what will contain the final Decree. The document should be made available in late December, and submitted to the advisory bodies such as the Superior Council of Health.

 

We feel it is of primary importance that you are fully informed of both the current state of the project and the joint efforts deployed by the VBS-GBS and BELNUC in order to reach a workable solution.  It is certain that this law will have a major effect on the daily practice of nuclear medicine. It will affect the clinical management of our patients, the general organization and the costs in ways that we cannot fully comprehend until we read the final document.

The BSS Directive, the proposal of the FANC-AFCN (July version), and our response are available below.

 

You are invited to a session of information jointly organized by the BVS-GBS and BELNUC on Saturday 13th January 2018 (see program below). We shall have the opportunity to discuss the final dispositions, their impact on our practice and the actions that we may have to take.

More info regarding venue and registration will follow.

 

 

Program (Accreditation for Ethics and Economy will be requested):

 

1. The BSS, the FANC/AFCN proposal and the common position of BELNUC-VBS-GBS : Prof. Drs Roland Hustinx & Christophe Deroose - Drs. Bart Dehaes & Gerard Moulin-Romsee

2. The position of the Belgian Hospital Physicists Association (BHPA): speaker to be announced

3. Round table - actions to be taken

 

 

 

Prof. Dr Roland Hustinx, President Belnuc

Prof. Dr Christophe Deroose, Secrertary General Belnuc

Dr Bart Dehaes, VBS-GBS

Dr. Gerard Moulin-Romsee, VBS-GBS